Zhuhai Trinomab Pharmaceutical Co Ltd

NEW
SHSE:688806 ()   Ordinary Shares - Class A
Â¥ 20.72 -0.95 (-4.38%) Sep 10
At Loss
P/B:
76.74
Market Cap:
Â¥ 9.54B ($ 1.42B)
Enterprise V:
Â¥ 10.28B ($ 1.53B)
Volume:
323.60M
Avg Vol (2M):
11.94M
Trade In:
Volume:
323.60M
At Loss
Avg Vol (2M):
11.94M

Zhuhai Trinomab Pharmaceutical Co Ltd (SHSE:688806) Dividend

Zhuhai Trinomab Pharmaceutical Co Ltd (SHSE:688806) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: SHSE:688806 Dividend

Does Zhuhai Trinomab Pharmaceutical Co Ltd (SHSE:688806) pay a dividend?

Zhuhai Trinomab Pharmaceutical Co Ltd (SHSE:688806) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Zhuhai Trinomab Pharmaceutical Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Zhuhai Trinomab Pharmaceutical Co Ltd has returned capital to shareholders via buybacks at a rate of -2.8% over the past 3 years.

What are dividend-paying alternatives to Zhuhai Trinomab Pharmaceutical Co Ltd?

For dividend-paying alternatives in Zhuhai Trinomab Pharmaceutical Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.